These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6956488)

  • 1. Effects of 5,8-dideazaisofolic acid (IAHQ) on human tumor cells in culture and on normal and tumor-bearing hamsters.
    Tsang KY; Hynes JB; Fudenberg HH
    Chemotherapy; 1982; 28(4):276-82. PubMed ID: 6956488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved synthesis and antitumor evaluation of 5,8-dideazaisofolic acid and closely related analogues.
    Hynes JB; Yang YC; McGill JE; Harmon SJ; Washtien WL
    J Med Chem; 1984 Feb; 27(2):232-5. PubMed ID: 6694171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
    Tsang KY; Fudenberg HH
    Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.
    Hynes JB; Smith AB; Gale GR
    Cancer Chemother Pharmacol; 1986; 18(3):231-4. PubMed ID: 3802378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and metabolism of 5,8-dideazaisofolic acid in human colon carcinoma cells.
    Sobrero AF; McGuire JJ; Bertino JR
    Biochem Pharmacol; 1988 Mar; 37(6):997-1001. PubMed ID: 2451526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5,8-dideazaisopteroylglutamate and its possible tri-gamma-glutamyl metabolite (5,8-dideazaisoPteGlu3) on colon adenocarcinoma, and the folate dependent enzymes thymidylate synthase and dihydrofolate reductase.
    Fernandes DJ; Cardenas RM; Bertino JR; Hynes JB
    Adv Exp Med Biol; 1983; 163():341-57. PubMed ID: 6688493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of analogues of 5,8-dideazaisofolic acid (IAHQ) modified at positions 2, 4 and 9.
    Hynes JB; Hagan RL; Shane B; Freisheim JH
    Adv Exp Med Biol; 1993; 338():417-20. PubMed ID: 8304148
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of three new folate antagonists on human breast adenocarcinoma cells in vitro and on immune responses in vivo.
    Tsang KY; Hynes JB; Fudenberg HH; Pan JF
    Chemotherapy; 1984; 30(1):61-8. PubMed ID: 6692721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
    Li WW; Lin JT; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of 5,8-dideazaisofolic acid and other quinazoline antifols in human colon carcinoma cells.
    McGuire JJ; Sobrero AF; Hynes JB; Bertino JR
    Cancer Res; 1987 Nov; 47(22):5975-81. PubMed ID: 3664501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of human tumor cell lines to antifolates.
    Diddens H; Niethammer D; Jackson RC
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():37-41. PubMed ID: 6234060
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines.
    Bodmer N; Walters DK; Fuchs B
    Pediatr Blood Cancer; 2008 Apr; 50(4):905-8. PubMed ID: 17534933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
    Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
    Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
    Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF; Bertino JR
    Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.